Bipyraloxifene – a modified raloxifene vector against triple-negative breast cancer-Reference-Cited by-同舟云学术

Bipyraloxifene – a modified raloxifene vector against triple-negative breast cancer

Published:2024 Issue:6 Volume:15 Page:1921-1928
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Kazimir Aleksandr¹^ORCID,Götze Tom¹^ORCID,Murganić Blagoje²^ORCID,Mijatović Sanja³^ORCID,Maksimović-Ivanić Danijela³^ORCID,Hey-Hawkins Evamarie¹^ORCID

Affiliation:

1. Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany

2. Institute of Nuclear Sciences “Vinča”, University of Belgrade, 12-14 Mike Petrovića Street, Belgrade 11351, Serbia

3. Department of Immunology, Institute for Biological Research “Siniša Stanković”, National Institute of Republic of Serbia, Belgrade University, Bul. despota Stefana 142, Belgrade 11060, Serbia

Abstract

The synthetic combination of raloxifene, a selective estrogen receptor modulator, with a 2,2′-bipyridine moiety results in bipyraloxifene, a potential drug with enhanced activity against triple negative breast cancer.

Funder

Deutscher Akademischer Austauschdienst

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MD/D4MD00051J

Reference53 articles.

1. Selective estrogen receptor modulators and bone health

2. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen

3. Selective Estrogen Receptor Modulators

4. The development of endocrine therapy for women with breast cancer

5. Triple-negative breast cancer molecular subtyping and treatment progress

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Raloxifene‐Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple‐Negative Breast Cancer;ChemMedChem;2024-06-05